Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including Beyaz, Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium, Safyral. Available dosage form: kit.
Drug details
- Generic Name
- Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
- Brand Names
- Beyaz, Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium, Safyral, Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium
- Application Number
- NDA022532
- Sponsor
- Bayer HealthCare Pharmaceuticals Inc.
- NDC Codes
- 4
- Dosage Forms
- KIT
Indications and Usage
1 INDICATIONS AND USAGE Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium is a combination of drospirenone, a progestin and ethinyl estradiol, an estrogen containing a folate, indicated for use by females of reproductive potential to: • Prevent pregnancy. ( 1.1 ) • Raise folate levels in females of reproductive potential who choose to use an oral contraceptive for contraception. ( 1.2 ) 1.1 Oral Contraceptive Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium is indicated for use by females of reproductive potential to prevent pregnancy. 1.2 Folate Supplementation Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium is indicated in females of reproductive potential who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.